A Study That Tests BI 1467335 in Patients With Diabetic Eye Disease (Diabetic Retinopathy). It Looks at the Way BI 1467335 is Taken up, the Effects it Has, and How Well it is Tolerated.

LKH-Univ. Hospital Graz, Graz

New York Eye and Ear Infirmary of Mount Sinai, New York

University of Pennsylvania, Philadelphia

Fondazione Centro San Raffaele del Monte Tabor, Milan

Cumberland Valley Retina Consultants, PC., Hagerstown

Hospital Clínico San Carlos, Madrid

Charlotte Eye Ear Nose and Throat Associates, PA, Charlotte

Florida Retina Institute, Orlando

Trinity Research, Dothan

Cleveland Clinic, Cleveland

Raj K. Maturi, MD PC, Indianapolis

Hospital Miguel Servet, Zaragoza

Interbalkan Medical Center of Thessaloniki, Thessaloniki

Northwestern Medical Group, Chicago

Retina Consultants of Houston, PA, Houston

Retina Research Center, PLLC, Austin

Retina Research Institute of Texas, Abilene

Retinal Research Institute, LLC, Phoenix

Retina-Vitreous Associates Medical Group, Beverly Hills

Stanford University Medical Center, Palo Alto

NJRetina, Teaneck

IRCCS Fondazione Bietti, Roma

Oslo Universitetssykehus HF, Ullevål sykehus, Oslo

CHUC - Centro Hospitalar e Universitário de Coimbra, EPE, Coimbra

Espaço Médico de Coimbra, Coimbra

CHULC, EPE - Hospital Sto. António Capuchos, Lisbon

Hospital Dos de Maig, Barcelona

Hospital Vall d'Hebron, Barcelona

Bradford Royal Infirmary, Bradford

Bristol Eye Hospital, Bristol

Frimley Park Hospital, Frimley

Moorfields Eye Hospital, London

Royal Victoria Infirmary, Newcastle upon Tyne

Hospital of St Cross, Rugby

Sunderland Eye Infirmary, Sunderland